Vascularized fibula grafts for reconstruction of bone defects after resection of bone sarcomas
- PMID: 20490263
- PMCID: PMC2871185
- DOI: 10.1155/2010/524721
Vascularized fibula grafts for reconstruction of bone defects after resection of bone sarcomas
Abstract
We evaluated the results of limb-sparing surgery and reconstruction of bone defects with vascularized fibula grafts in 8 consecutive patients (mean age at operation 13.6 years (range 4.1-24.2 years), female/male = 6/2) with bone sarcomas (BS) (osteosarcoma/Ewing's sarcoma/chondrosarcoma= 4/3/1) operated on form 2000 to 2006. The bone defects reconstructed were proximal femoral diaphysis and epiphysis (n = 2), humeral diaphysis (n = 2), humeral proximal diaphysis and epiphysis (n = 1), femoral diaphysis (n = 1), ulnar diaphysis (n = 1), and tibial diaphysis (n = 1). One patient with Ewing's sarcoma had an early hip disarticulation, developed multiple metastases, and died 9 months after the operation. The remaining patients (n = 7) are all alive 50 months (range 26-75 months) after surgery. During the follow-up the following major complications were seen: 1-2 fractures (n = 4), pseudarthrosis (n = 2), and hip dislocation (n = 1). Limb-sparing surgery with reconstruction of bone defects using vascularized fibular grafts in BS cases is feasible with acceptable clinical results, but fractures should be expected in many patients.
Figures
References
-
- Bernstein M, Kovar H, Paulussen M, et al. Ewing’s sarcoma family of tumors: current management. Oncologist. 2006;11(5):503–519. - PubMed
-
- Grimer RJ. Surgical options for children with osteosarcoma. The Lancet Oncology. 2005;6(2):85–92. - PubMed
-
- Osteosarcoma: advances in treatment or changing naural history. The Lancet. 1978;320(8080):82–83. - PubMed
-
- Ferrari S, Smeland S, Mercuri M, et al. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. Journal of Clinical Oncology. 2005;23(34):8845–8852. - PubMed
-
- Elomaa I, Blomqvist CP, Saeter G, et al. Five-year results in Ewing’s sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol. European Journal of Cancer. 2000;36(7):875–880. - PubMed
LinkOut - more resources
Full Text Sources
